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Pandemic Influenza — Research
with nH1N1 and 9.7% of those admitted to
an intensive care unit (ICU) with nH1N1.1,2
However, these nationwide figures may not
reveal the true extent of the impact of
nH1N1 on jurisdictions with sizeable Indig-
enous populations.
The Top End of the Northern Territory of
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Objective:  To describe the impact of pandemic (H1N1) 2009 influenza (nH1N1) on 
Indigenous people in the Top End of the Northern Territory at community, hospital and 
intensive care unit (ICU) levels.
Design, setting and participants:  We analysed influenza notifications for the Top End 
from 1 June to 31 August 2009, as well as data on patients admitted through Top End 
emergency departments with an influenza-like illness. In addition, data on patients with 
nH1N1 who were admitted to Royal Darwin Hospital (RDH) and the RDH ICU were 
prospectively collected and analysed.
 outcome measures:  Age-adjusted notification rates for nH1N1 cases, Top End 
ital admission rates for patients with nH1N1 and RDH ICU admission rates for 
nts with nH1N1, stratified by Indigenous status.
lts:  There were 918 nH1N1 notifications during the study period. The age-adjusted 
ital admission rate for nH1N1 was 82 per 100 000 (95% CI, 68–95) estimated resident 
lation (ERP) overall, with a markedly higher rate in the Indigenous population 
compared with the non-Indigenous population (269 per 100 000 versus 29 per 100 000 
ERP; adjusted incidence rate ratio, 12 [95% CI, 7.8–18]). Independent predictors of ICU 
admission compared with hospitalisation were hypoxia (adjusted odds ratio [aOR], 4.5; 
CI, 1.5–13.1) and chest x-ray infiltrates (aOR, 4.3; CI, 1.5–12.6) on hospital admission.
Conclusions:  Pandemic (H1N1) 2009 influenza had a disproportionate impact on 
Indigenous Australians in the Top End, with hospitalisation rates higher than those 
reported elsewhere in Australia and overseas. These findings have implications 
for planning hospital and ICU capacity during an influenza pandemic in regions with 
large Indigenous populations. They also confirm the need to improve health and living 
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circumstances and to prioritise vaccination in this population.
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infT  Australian response to the firstve of pandemic (H1N1) 2009luenza (nH1N1) has included the
identification of vulnerable populations, to
whom early treatment and careful follow-up
has been targeted.1 One of these popula-
tions, Indigenous Australians, comprises
2.5% of the Australian population but
accounted for 16% of patients hospitalised
Australia is unique for its small, widely
dispersed population of 172 000 in an area
of 477 000 square kilometres and its high
proportion (26.5%) of Indigenous Austral-
ians.3,4 There are high rates of chronic dis-
ease in the Indigenous population,5 whose
levels of mobility between communities,6
inadequate health hardware (eg, taps, hot
water, toilets, drains),7 and overcrowded
living conditions are likely to facilitate
spread of the nH1N1 virus.8 Here, we
describe the impact of nH1N1 on this vul-
nerable population.
METHODS
Design and setting
The Top End of the NT encompasses the
administrative regions of Darwin, Katherine
and East Arnhem and is served by the Royal
Darwin Hospital (RDH), a 350-bed tertiary
referral centre containing the region’s only
ICU, and two small regional hospitals. Dur-
ing the study period — 1 June 2009 to 31
August 2009 — all of these hospitals imple-
mented a consistent policy of influenza
screening for all patients presenting with an
influenza-like illness (ILI).
We collected and analysed data on: all
Top End nH1N1 notifications (notification
analysis); all patients admitted through Top
End emergency departments with an ILI (ILI
analysis); all patients admitted to the RDH
with nH1N1 (RDH admission analysis); and
all patients admitted to the RDH ICU with
nH1N1 (ICU analysis).
Definitions
An ILI was defined as a fever (temperature
38ºC or a documented fever history) with
a cough and/or sore throat.9 Influenza A was
diagnosed by polymerase chain reaction
(PCR) analysis of combined nose and throat
swabs, and nH1N1 was diagnosed by PCR
analysis using primers specific for the
nH1N1 haemagglutinin gene.10
 Remote dwelling was defined using the
Australian Bureau of Statistics remoteness
area (RA) classification,11 with urban defined
as RA code 2 and remote as RA code 3 or 4.
Data collection
For the notification analysis, population-
level notification data were provided by the
NT Centre for Disease Control. Before 18
June 2009, testing of anyone presenting to a
health care facility with an ILI was encour-
aged; after this time, only those with severe
disease or underlying risk factors were
tested — in line with national policy.9
For the ILI analysis, hospital admission
records were linked with influenza testing
data obtained from the RDH microbiology
laboratory. We included all patients who
were admitted through an emergency
department or maternity ward of a hospital
in the region during the study period and
had a specimen taken for influenza A PCR
analysis within 48 hours of admission
(before or after). In cases where a person
had multiple admissions fulfilling these cri-
teria, the first influenza A-positive admis-
sion was included; if none were influenza A
positive, the first admission was included.MJA • Volume 192 Number 10 • 17 May 2010 617
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admission and in-hospital mortality were
obtained from hospital databases.
For the RDH admission analysis, the
admitting hospital team prospectively col-
lected detailed clinical data on standardised
case record forms for all patients admitted
non-electively to RDH from the community
with nH1N1. Completeness of the dataset
was ensured by cross-checking with the ILI
analysis dataset, and missing data were
obtained retrospectively. Symptoms, initial
vital signs, laboratory results and comorbid-
ities were recorded. Obesity was based on a
clinical estimate of body mass index of more
than 30 kg/m2. Patients categorised as preg-
nant included those diagnosed with nH1N1
within 5 days after giving birth.
For the ICU analysis additional ICU-spe-
cific data were collected prospectively by
RDH ICU staff for the Australian and New
Zealand Intensive Care Society registry.2 Daily
ICU bed occupancy was defined as the pro-
portion of the eight beds staffed for ventilated
patients occupied each day, and could exceed
100%.
The study was approved by the Human
Research Ethics Committee of the Menzies
School of Health Research and the NT
Department of Health and Families (DHF)
as a quality assurance activity.
Statistical analysis
Continuous variables were compared using
the Mann–Whitney U test. Categorical varia-
bles were compared using the χ2, Fisher
exact or Wilcoxon rank sum tests as appro-
priate. Non-annualised incidence rates were
calculated for the region using 2008 NT
population data provided by the Health
Gains Unit of the NT DHF. These were
standardised to the 2001 Australian stand-
ard population using the direct method.12
Adjusted incidence rate ratios (IRRs) were
derived using a Poisson regression model. A
univariate analysis was performed for the ILI
analysis. In the RDH admission analysis,
patients requiring ICU care were compared
with those not requiring ICU care. Clinically
important variables and those with P < 0.25
in the univariate analysis were included in
an initial logistic regression model with
backwards stepwise elimination of variables.
Further univariate analyses were performed
comparing Indigenous patients with non-
Indigenous patients. Statistical analyses
were performed using STATA version 11
(StataCorp, College Station, Tex, USA). Two-
sided P values of < 0.05 were considered
significant.
RESULTS
The numbers and categories of notifications
and patients included in the four parts of
this study are summarised in Box 1.
Notification analysis
A total of 918 cases of nH1N1 in the Top
End were notified during the study period.
This corresponds to an age-adjusted notifi-
cation rate of 497 (95% CI, 494–500) per
100 000 estimated resident population
(ERP). There were 473 female (51.5%) and
445 male (48.5%) cases. The number of
notifications increased sharply in Week 5
(25 June – 1 July) and peaked in Week 7 (9–
15 July) (Box 2).
The median age (interquartile range
[IQR]) for notifications was 25 (15–40)
years. Indigenous people accounted for
54.9% of notifications (463/844 where data
on Indigenous status was available). Of
patients included in the notification analy-
sis, the median age (IQR) for Indigenous
patients was 23 (11–41) years and for non-
Indigenous patients was 25 (19–38) years.
The age-adjusted notification rate for the
Indigenous population was 1116 (95% CI,
1111–1120) per 100 000 ERP, 3.5 times
that for the non-Indigenous population
(315 [95% CI, 312–317] per 100 000
ERP).
ILI analysis
During the study period, 643 patients were
admitted through Top End emergency
departments with an ILI. Of these patients,
161 (25%) tested positive for nH1N1, a
further 50 (8%) tested positive for seasonal
influenza A, and 432 (67%) had a non-
influenza A febrile respiratory illness (Box
3). Indigenous patients were over-repre-
sented in all three of these patient groups,
and accounted for 72% of those who tested
positive for nH1N1. There was no signifi-
cant difference in either the need for ICU
admission or in-hospital mortality between
the three groups.
The overall age-adjusted incidence of
admission with an ILI was 361 per 100 000
ERP over the study period. The correspond-
ing incidence rate for nH1N1 was 82 per
100 000 ERP overall, with stark differences
between Indigenous and non-Indigenous
populations (269 [95% CI, 214–324]) v 29
[95% CI, 20–39] per 100 000 ERP). The
adjusted IRR for nH1N1 admission was 12
(95% CI, 7.8–18; adjusted for age and
remoteness) and the IRR for ICU admission
was 5.2 (95% CI, 2.3–12) — both calcu-
lated for Indigenous versus non-Indigenous
patients (Box 4). For the Indigenous popula-
tion alone, the IRR of hospital admission for
remote compared with urban dwelling was
0.63 (95% CI, 0.43–0.92).
1 Summary of influenza notifications and patient groups from the Top End of 
the Northern Territory (1 June to 31 August 2009) included in this study
ILI = influenza-like illness. RDH = Royal Darwin Hospital. ICU = intensive care unit. ◆
RDH admission analysis
ILI analysis
Notiﬁcation analysis
Admitted to RDH 
from community
(n = 32)
Admitted to RDH
ICU (n = 21)
Not admitted to RDH
ICU (n = 110)
Admitted to RDH 
from community
(n = 131)
Pandemic (H1N1)
2009 inﬂuenza
positive (n = 161)
Non-inﬂuenza A
febrile respiratory
 illness (n = 432)
Seasonal inﬂuenza A
positive
(n = 50)
Admitted to a Top End
hospital with ILI
(n = 643)
Pandemic (H1N1) 2009 inﬂuenza
notiﬁcations in the Top End
(n = 918)
ICU analysis
All RDH ICU admissions including six interhospital
transfers and one nosocomial acquisition (n = 28)618 MJA • Volume 192 Number 10 • 17 May 2010
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through Top End emergency departments
with an ILI, hospital admissions for nH1N1
and non-influenza ILI peaked in Weeks 7 and
8 (9–22 July), whereas those for seasonal
influenza A peaked in Week 6 (2–8 July).
RDH admission analysis
Of the 161 patients who were positive for
nH1N1, 131 were admitted to RDH from
the community; 21 of these patients (16%)
required ICU admission, and two died.
Within the group admitted from the com-
munity, there were 24 women aged 15–45
years, of whom 11 (46%) were classified as
pregnant. Three of those 11 were admitted
to ICU. Nosocomial acquisition was noted
in 10 patients who were admitted to RDH
and subsequently tested positive for nH1N1
at greater than 48 hours after admission;
these patients were not considered in the
RDH admission analysis.
Unusual presenting symptoms in patients
admitted to RDH with community-acquired
nH1N1 included chest pain in 20 patients
(15%) and seizures in five patients (of whom
three were children with febrile convul-
sions). The median (IQR) duration of symp-
toms before admission was 3 (1–5) days.
Oseltamivir or zanamivir were administered
to 107 patients (82%), including 99 of 109
(91%) of those aged  5 years, but only
eight of 22 (36%) of those aged < 5 years.
There were significant differences
between Indigenous and non-Indigenous
patients admitted with nH1N1 (Box 5).
Indigenous patients were more likely to live
remotely and were younger, with lower hae-
moglobin and serum albumin levels, and
higher white cell counts and C-reactive pro-
tein (CRP) levels than non-Indigenous
patients. The proportions of patients who
reported being a current smoker and
patients who reported hazardous alcohol
use were also higher in Indigenous patients.
On univariate analysis, serum albumin
< 35g/L (odds ratio, 3.5), elevated CRP levels,
infiltrates on chest x-ray and hypoxia were
significantly associated with ICU admission.
Obesity was associated with an odds ratio of
2.4, which was not statistically significant.
Details of the univariate analysis are available
from the authors. On multivariate logistic
regression, only hypoxia (adjusted odds ratio
[aOR], 4.5; 95% CI, 1.5–13.1) and chest x-ray
infiltrates (aOR, 4.3; 95% CI, 1.5–12.6) on
initial hospital admission were significantly
associated with ICU admission. Indigenous
status and pregnancy were not significant in
either of these analyses.
3 Characteristics of patients admitted for acute care to Top End hospitals with 
an influenza-like illness (ILI), by result of influenza testing (1 June to 31 August 
2009)*
* Data are number (%) or median (interquartile range) unless otherwise indicated. † χ2 test on 
3 2 table. ‡ Kruskal–Wallis rank test. § χ2 test on pandemic (H1N1) 2009 influenza  non-
influenza A. ¶ χ2 test on pandemic (H1N1) 2009 influenza  influenza A. ** Remoteness data do 
not include 56 people with usual place of residence outside of the Top End. ◆
Pandemic (H1N1) 
2009 influenza 
(n = 161)
Seasonal 
influenza A 
(n = 50)
Non-influenza A 
febrile respiratory 
illness (n = 432)
Total 
(n = 643) P
Female 84 (52%) 29 (58%) 198 (46%) 311 (48%) 0.13†
Age (years) 40 (19–51) 38 (2–58) 40 (11–57) 40 (12–55) 0.70‡
Age 60 years 23 (14%) 12 (24%) 98 (23%) 133 (21%) 0.07†
Indigenous 116 (72%) 30 (60%) 236 (55%) 382 (59%) < 0.01§
0.11¶
Remoteness**
Remote 74 (49%) 30 (64%) 182 (47%) 286 (49%) 0.09†
Non-remote 76 (51%) 17 (36%) 208 (53%) 301 (51%)
Intensive care unit 27 (17%) 5 (10%) 46 (11%) 78 (12%) 0.26†
Died 4 (2%) 1 (2%) 9 (2%) 14 (2%) 0.95†
2 Notifications and RDH admissions (A) and RDH ICU admissions (B) for 
pandemic (H1N1) 2009 in the Top End of the Northern Territory by week 
(1 June to 31 August 2009)
RDH = Royal Darwin Hospital. ICU = intensive care unit. ◆
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Twenty-eight of the 161 patients in the Top
End who were positive for nH1N1 (17%)
were admitted to the RDH ICU; this
included six interhospital transfers and one
nosocomial acquisition. The median (IQR)
APACHE (Acute Physiology and Chronic
Health Evaluation) II score for these patients
was 16 (14–23), and four patients died. The
average daily ICU bed occupancy was 110%
and nH1N1 admissions contributed 23% of
this load. The median (IQR) length of stay
was 4.5 (1.0–6.7) days. Admission of
patients positive for nH1N1 to the RDH ICU
peaked in Week 8 (16–22 July) (Box 2).
Intubation and mechanical ventilation
was required for 17 of the 28 ICU patients,
with a median (IQR) duration of 121 (47–
293) hours. Inhaled nitric oxide was used in
three patients, high frequency oscillatory
ventilation in two patients, and prone posi-
tioning in one patient. Extracorporeal mem-
brane oxygenation (ECMO) was not
available at RDH and no patients were trans-
ferred elsewhere for ECMO. Two patients
had rhabdomyolysis (peak creatine kinase
levels, 82 000 IU/L and 42 000 IU/L [refer-
ence range, 0–220 IU/L]), of whom one
died.
DISCUSSION
In the Top End of northern Australia,
nH1N1 had a disproportionate impact on
the Indigenous population at community,
hospital and ICU levels. Rates of notifica-
tion, hospital admission and ICU admission
were 3.5 times, 12 times and 5 times higher,
respectively, than for the non-Indigenous
population. In contrast, hospital and ICU
admission rates for the non-Indigenous
population in this region were equivalent to
those for Australia as a whole.2,13 The hospi-
tal admission rates in the Top End are
significantly higher than those reported for
Australia overall and overseas.13,14 This is
true for the overall hospital admission rate
that includes both Indigenous and non-
Indigenous populations, but is particularly
so for the Indigenous population alone.
One of the strengths of this study was that
we were able to collect data on all patients
admitted to hospital and ICU with nH1N1
in the entire region. This was enabled by an
active surveillance program, a small number
of hospitals, linkage of data by unique
patient identification numbers, and a policy
of broad testing of hospitalised patients.
Thus, the hospital and ICU admission rates
are likely to reflect population-based inci-
dence and are not subject to ascertainment
bias toward tertiary referral centres, as
would be likely for similar studies based in
larger cities.
It is possible that the actual nH1N1
admission rates were higher than estimated
here. Although PCR analysis of optimal sam-
ples has a sensitivity of nearly 100%,15 the
similar demographics, outcomes and epi-
demic curves for non-influenza ILI and
nH1N1 raise the possibility that a propor-
tion of the non-influenza ILI cases were false
negatives. Alternatively, other circulating
respiratory viruses may have caused similar
clinical presentations.
Several factors are likely to underpin high
admission rates for the Indigenous popula-
tion. First, we infer an excess incidence of
nH1N1 cases within the Indigenous popula-
tion from the high notification rate for this
group. Although this may reflect differential
testing driven by additional comorbidities in
the Indigenous population, it is consistent
with the distribution of early notifications in
the NT when testing was universal.16 Likely
explanations for this include a highly mobile
Indigenous population, crowded living cir-
cumstances and inadequate health hard-
ware.6-8 Such conditions contribute to the
transmission of skin pathogens, and a simi-
lar effect may occur with pathogens trans-
mitted by aerosol and droplet spread.17,18
The lack of adequate housing and subse-
quent overcrowding in Indigenous commu-
nities is particularly striking — recent
studies have found that dwellings in Indige-
nous communities house a mean of 3.4
persons per bedroom, and up to 7.5 persons
per bedroom.19,20
Second, Indigenous populations world-
wide have a high prevalence of risk factors
for severe influenza.21,22 Among Indigenous
people living in the Top End, the popula-
tion-based prevalence of chronic lung dis-
ease has been estimated at eight per cent,
four times higher than the comparable age-
adjusted Australian rate, and a similar excess
has been shown for the other major comor-
bidities.5 Given this substantial underlying
disparity, it is noteworthy that there were
few differences in risk factors between
Indigenous and non-Indigenous hospital-
ised patients in our study. This suggests that
excess comorbidities contributed to the high
hospitalisation rates among Indigenous peo-
ple (otherwise the differences in risk factors
would have been preserved).
Reports to date have consistently found
that Indigenous people with nH1N1 are
over-represented in ICUs.2,23 Our data sug-
4 Rates of admission to hospital (A) and ICU (B) with pandemic (H1N1) 2009 
influenza in previous studies2,13,14 and this study (Top End, Northern 
Territory)*
ICU = intensive care unit. * Rates are non-annualised, age-standardised unless otherwise 
indicated; 95% confidence intervals are shown where available; and rates for this study 
represent data for the three Top End hospitals for the period 1 June to 31 August 2009 based 
on estimated resident population. † Not age-standardised. ◆
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PANDEMIC IN FLUENZA —  RESEARCHgest that this over-representation flows from
an excess of community and hospital cases,
rather than an environmentally or geneti-
cally determined susceptibility to severe dis-
ease as has been hypothesised.23 We
observed a similar pattern with pregnant
women, who were over-represented in the
hospital admissions (46% of women of
child-bearing age) but not the ICU admis-
sions. A previous study showed that 25% of
all women admitted with nH1N1 in Mel-
bourne were pregnant.24 However, by
restricting the denominator to women of
child-bearing age this figure becomes a more
comparable 38% (Justin Denholm, Infec-
tious Diseases Physician, Victorian Infectious
Diseases Service, personal communication).
Risk factors that were associated with ICU
admission on multivariate analysis were
hypoxia and chest x-ray infiltrates. Although
both obesity and hypoalbuminaemia were
more than twice as common in ICU patients
on univariate analysis, neither were signifi-
cant on multivariate analysis. A high preva-
lence of obesity in ICU patients with nH1N1
has been reported elsewhere,2,23 and
hypoalbuminaemia has been shown to be
associated with severe nH1N1 infection25
and ICU admission in Top End patients with
community-acquired pneumonia.26 The
absence of associations between severe
nH1N1 disease and obesity and hypoalbu-
minaemia on multivariate analysis may be
due to a small sample size.
The consistently high ICU bed occupancy
observed during the study period was due to
the substantial burden of nH1N1 on critical
care resources. The nH1N1-related bed
occupancy of 23% was higher than the 5.2%
reported across Australasia,2 and directly
affected the capacity of the RDH as both a
remote regional ICU and as the National
Critical Care and Trauma Response Centre.
The mortality rate of 14% for patients who
were admitted to the RDH ICU (four deaths
among 28 patients) was comparable to
national figures.2 We noted two cases of
severe hyperthermia and rhabdomyolysis
with nH1N1; to date, this brings the total
number of rhabdomyolysis cases reported
worldwide to four.27 Lack of access to
ECMO did not appear to adversely affect
outcomes, which is reassuring for other
jurisdictions without access to ECMO.
In conclusion, pandemic (H1N1) 2009
influenza has disproportionately affected the
Indigenous population of the NT. This is
likely to be due to a combination of
increased attack rates and a high prevalence
of comorbidities in this population. These
5 Characteristics of patients admitted to Royal Darwin Hospital with pandemic 
(H1N1) 2009 influenza, by Indigenous status (1 June to 31 August 2009)*
COPD = chronic obstructive pulmonary disease. RR = reference range. * Data are number (%) or 
median (interquartile range) unless otherwise indicated. Where data are missing or excluded, 
denominators are specified. † χ2 test. ‡ Wilcoxon rank sum test. § 11 people with usual place of 
residence outside of the Top End were not included in the remoteness classification. ¶ Fisher’s 
exact test. ** Children < 16 years are excluded due to different normal values. †† Hypoxia 
defined as either SaO2 < 93% on room air or PaO2/FiO2 < 300 mmHg. ◆
Non-Indigenous 
(n = 39)
Indigenous 
(n = 92) P
Female 14 (36%) 49 (53%) 0.07†
Age (years) 46 (19–61) 39 (15.5–49) 0.04‡
Duration of symptoms (days) 3 (2–7) 3 (1–4) 0.27‡
Remote dwelling§ 2/32 (6%) 43/88 (49%) < 0.01¶
Risk factors
Asthma 10 (26%) 16 (17%) 0.28†
COPD 9 (23%) 16 (17%) 0.45†
Bronchiectasis 2 (5%) 7 (8%) 0.72¶
Obesity 6 (15%) 8 (9%) 0.26†
Cardiac disease 8 (21%) 21 (23%) 0.77†
Diabetes 8 (21%) 22 (24%) 0.67†
Chronic liver disease 2 (5%) 10 (11%) 0.30¶
Chronic kidney disease 2 (5%) 18 (20%) 0.04¶
Neurological disease 4 (10%) 5 (5%) 0.45¶
Immunosuppression 3 (8%) 3 (3%) 0.36¶
Current smoker 5 (13%) 38 (41%) < 0.01¶
Hazardous alcohol use 3 (8%) 24 (26%) 0.02¶
Pregnant 3 (8%) 8 (9%) 1.00¶
1 comorbidity 28 (72%) 68 (74%) 0.80†
Initial vital signs on hospital admission
Heart rate 
(beats/min)**
100 (84–120)
(n = 32)
105 (88–118)
(n = 69)
0.64‡
Respiratory rate 
(breaths/min)**
24 (20–28)
(n = 31)
24 (22–32)
(n = 67)
0.24‡
Temperature (° C) 37.8 (36.8–38.6) 37.4 (36.7–38.4) 0.29‡
Systolic blood pressure 
(mmHg)**
130 (112–145)
(n = 32)
125 (105–148)
(n = 69)
0.50‡
Hypoxia†† 16/38 (42%) 31/86 (36%) 0.52†
Initial investigations
Haemoglobin (g/L) 
(RR, 115–165g/L)
139 (120–148)
(n = 37)
126 (109–143)
(n = 91)
0.02‡
White cell count  109/L 
(RR, 4.0–11.0  109/L)
8.7 (6.1–10.9)
(n = 38)
11.4 (8.1–14.5)
(n = 91)
< 0.01‡
Serum albumin (g/L) 
(RR, 35–45 g/L)
41 (38–45)
(n = 31)
37 (31–41)
(n = 69)
< 0.01‡
C-reactive protein (mg/L) 
(RR, 0.0–5.0 mg/L)
31.5 (11–82)
(n = 34)
50.8 (25.6–97.2)
(n = 80)
0.02‡
Infiltrates on chest x-ray 16/39 (41%) 34/87 (39%) 0.84†MJA • Volume 192 Number 10 • 17 May 2010 621
PANDEMIC IN FLUENZA —  RESEARCHfindings have significant implications for
planning hospital and ICU capacity during
an influenza pandemic in regions with large
Indigenous populations. They also confirm
the need to improve health and living cir-
cumstances and prioritise vaccination in this
population.
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